SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Aspira Pathlab & Diagnostics L

BSE: 540788 30 Sep 2025
Healthcare
₹ 65.02
Aspira Pathlab & Diagnostics Limited specializes in Healthcare Service Provider within the Healthcare sector.

Aspira Pathlab & Diagnostics L - Share Price & Details

Market Cap
₹60.7
High /Low
107.0 / 39.6
Stock P/E
25.3
Book Value
₹7.02
Dividend Yield
0.0
ROCE
17.0
ROE
₹33.0
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹17.2
Debt
8.13
CMP / FCF
NA
Debt to equity
₹1.12
NP Ann
2.02
High price all time
124.0
Piotroski score
₹7.0
Graham Number
19.2
No. Eq. Shares
1.03
Net CF
₹0.95
Net profit
2.40
Price to book value
8.4
Interest Coverage
₹NA
Low price all time
14.2
Industry PE
38.6
Reserves
₹-3.06
Free Cash Flow
₹1.66

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Aspira Pathlab & Diagnostics LNANANANA60.725.3
VASUNDHARA RASAYANS LTDNANANANA58.214.8
BACIL PHARMA LTD.NANANANA57.952.2

Peer Comparison Chart


About Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics Limited, with Security Code 540788, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Aspira Pathlab Reports Significant Profit Growth and Strong Market Performance

(10 Sep 2025)
Aspira Pathlab & Diagnostics has recently experienced a change in evaluation, reflecting strong financial trends. The company reported a significant...
Read more →

Aspira Pathlab Experiences Technical Shift Amid Continued Financial Growth and Stability

(18 Aug 2025)
Aspira Pathlab & Diagnostics has recently experienced an evaluation adjustment reflecting changes in its technical indicators, with a shift towards...
Read more →

Is Laxmi Organic Industries Limited (543277) a Good Long Term Bet - Robust investment performance

(16 Aug 2025)
【Stock Analysis】✌️ Maximize your returns with expert-led investment strategies that integrate real-time market data, cutting-edge analytics...
Read more →

Aspira Pathlab Reports Strong Financial Growth and Operational Achievements in June 2025

(13 Aug 2025)
Aspira Pathlab & Diagnostics has announced its financial results for the quarter ending June 2025, showcasing significant growth.
Read more →

Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y

(11 Aug 2025)
Quarterly Net Profit at Rs. 0.42 crore in June 2025 up 794.9% from Rs. 0.05 crore in June 2024. EBITDA stands at Rs. 0.93 crore in June 2025...
Read more →

aspira pathlab and diagnostics to convene board meeting

(06 Aug 2025)
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 August 2025.
Read more →